Tfg Asset Management Gp LTD Autolus Therapeutics PLC Transaction History

Tfg Asset Management Gp LTD

  • $268 Million
  • Q3 2024

A detailed history of Tfg Asset Management Gp LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 8,000,000 shares of AUTL stock, worth $23.9 Million. This represents 10.85% of its overall portfolio holdings.

Number of Shares
8,000,000
Previous 8,000,000 -0.0%
Holding current value
$23.9 Million
Previous $27.8 Million 4.31%
% of portfolio
10.85%
Previous 9.47%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$3.33 - $5.68 $1.58 Million - $2.69 Million
474,318 Added 6.3%
8,000,000 $27.8 Million
Q1 2024

May 15, 2024
SELL
$5.39 - $7.29 $2.56 Million - $3.46 Million
-474,318 Reduced 5.93%
7,525,682 $48 Million
Q4 2023

Feb 14, 2024
SELL
$2.13 - $6.63 $8.52 Million - $26.5 Million
-4,000,000 Reduced 33.33%
8,000,000 $51.5 Million
Q2 2023

Aug 14, 2023
BUY
$1.64 - $3.21 $3.28 Million - $6.42 Million
2,000,000 Added 20.0%
12,000,000 $28.6 Million
Q1 2023

May 15, 2023
BUY
$1.75 - $2.25 $2.98 Million - $3.83 Million
1,700,000 Added 20.48%
10,000,000 $18.4 Million
Q4 2022

Feb 14, 2023
BUY
$1.74 - $3.27 $9.15 Million - $17.2 Million
5,260,619 Added 173.08%
8,300,000 $15.8 Million
Q3 2022

Nov 14, 2022
BUY
$2.04 - $3.76 $40,734 - $75,079
19,968 Added 0.66%
3,039,381 $6.5 Million
Q2 2022

Aug 15, 2022
BUY
$2.04 - $4.68 $394,691 - $905,467
193,476 Added 6.85%
3,019,413 $8.55 Million
Q1 2022

May 16, 2022
BUY
$3.52 - $5.46 $443,298 - $687,616
125,937 Added 4.66%
2,825,937 $11.8 Million
Q4 2021

Feb 14, 2022
BUY
$5.1 - $7.0 $1.02 Million - $1.4 Million
200,000 Added 8.0%
2,700,000 $14 Million
Q2 2021

Aug 16, 2021
BUY
$4.78 - $7.96 $307,287 - $511,716
64,286 Added 2.64%
2,500,000 $16.6 Million
Q1 2021

May 17, 2021
BUY
$5.49 - $9.36 $1.57 Million - $2.67 Million
285,714 Added 13.29%
2,435,714 $14 Million
Q2 2020

Aug 14, 2020
BUY
$5.38 - $16.14 $900,606 - $2.7 Million
167,399 Added 8.44%
2,150,000 $34.5 Million
Q1 2020

May 15, 2020
BUY
$4.2 - $13.0 $2.87 Million - $8.87 Million
682,601 Added 52.51%
1,982,601 $11.9 Million
Q3 2019

Nov 14, 2019
BUY
$9.79 - $16.72 $2.94 Million - $5.02 Million
300,000 Added 30.0%
1,300,000 $16.1 Million
Q2 2019

Aug 14, 2019
BUY
$15.1 - $31.25 $2.24 Million - $4.64 Million
148,369 Added 17.42%
1,000,000 $16.1 Million
Q1 2019

May 15, 2019
BUY
$24.38 - $34.71 $1.26 Million - $1.79 Million
51,631 Added 6.45%
851,631 $26.8 Million
Q4 2018

Feb 14, 2019
BUY
$24.21 - $48.01 $238,468 - $472,898
9,850 Added 1.25%
800,000 $26.3 Million
Q3 2018

Nov 14, 2018
BUY
$20.86 - $33.33 $16 Million - $25.5 Million
765,150 Added 3060.6%
790,150 $24.2 Million
Q2 2018

Aug 14, 2018
BUY
$25.0 - $27.75 $625,000 - $693,750
25,000 New
25,000 $670,000

Others Institutions Holding AUTL

# of Institutions
104
Shares Held
163M
Call Options Held
2.8K
Put Options Held
13.4K
View Full List

About Autolus Therapeutics plc

AUTL Quotes by TradingView
  • Ticker AUTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,909,800
  • Market Cap $272M
  • Description
  • Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...
More about AUTL
Track This Portfolio

Track Tfg Asset Management Gp LTD Portfolio

Follow Tfg Asset Management Gp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfg Asset Management Gp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tfg Asset Management Gp LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email